GLP-1s: Semaglutide & Tirzepatide

What Is GLP-1 Therapy?

GLP-1 therapy (semaglutide or tirzepatide) may be considered for adults who have been unable to achieve adequate weight loss through diet and exercise alone, have weight-related health conditions, or are seeking a medically supervised weight management option.

This therapy involves the use of injectable medications, such as semaglutide or tirzepatide, prescribed when clinically appropriate by a licensed healthcare provider. These medications act on the glucagon-like peptide-1 (GLP-1) receptor to support appetite regulation and glycemic control. When combined with diet and lifestyle modifications, GLP-1 therapy may slow gastric emptying and increase satiety, which can contribute to reduced caloric intake.

Benefits of GLP-1 Therapy

  • Reduced appetite and fewer cravings

  • Sustainable weight loss over time

  • Improved blood sugar control

  • Increased energy and confidence

  • Medically supervised and personalized care

Monthly GLP-1 Wellness Program: (Semaglutide/ Tirzepatide: $350/450)

  • Prescriptions delivered to your doorstep

  • Comprehensive medical evaluation ($125 initial visit fee)

  • Personalized dosing and treatment plan

  • Same monthly fee no matter dosage

  • Ongoing provider monitoring and clinical support

  • Lifestyle and wellness guidance for long-term success

An initial consultation ($125 fee) includes a comprehensive 30-minute medical evaluation to assess your health history, goals, and candidacy for GLP-1 therapy.

Book your appointment today.

Want to learn more about service pricing?

GLP-1 therapy is not appropriate for all individuals. Results may vary. All medications are prescribed only after a comprehensive medical evaluation by a licensed healthcare practitioner authorized to practice in the State of Alabama. This content is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Participation in any medical weight management program requires an established provider–patient relationship and clinical determination of medical necessity. Patients should consult with a qualified healthcare provider to determine whether GLP-1 therapy is appropriate based on their individual medical history, health status, and treatment goals.